Evidence map›Paper›PMID 19951897›Full record

ReviewThe Journal of cell biology2010

Pericentrin in cellular function and disease.

Benedicte Delaval, Stephen J Doxsey

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 194 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Risk of Alzheimer's disease in Down syndrome: Insights gained by multi-omics.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Benedicte DelavalProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Stephen J Doxsey
University of Massachusetts Chan Medical School · US

Funding

Mitotic functions of cilia proteinsR01GM051994 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DOXSEY, STEPHEN J · 1995 to 2014
$4.3M
Centrosome and mitotic functions of ciliary proteinsR56GM051994 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DOXSEY, STEPHEN J · 2009 to 2009
$375k
NIGMS NIH HHS GM051994-14NIGMS NIH HHS R01 GM051994NIGMS NIH HHS R56 GM051994
6 · The paper itself

Abstract

Pericentrin is an integral component of the centrosome that serves as a multifunctional scaffold for anchoring numerous proteins and protein complexes. Through these interactions, pericentrin contributes to a diversity of fundamental cellular processes. Recent studies link pericentrin to a growing list of human disorders. Studies on pericentrin at the cellular, molecular, and, more recently, organismal level, provide a platform for generating models to elucidate the etiology of these disorders. Although the complexity of phenotypes associated with pericentrin-mediated disorders is somewhat daunting, insights into the cellular basis of disease are beginning to come into focus. In this review, we focus on human conditions associated with loss or elevation of pericentrin and propose cellular and molecular models that might explain them.

Indexed as

AnimalsAntigensCell DeathCentrosomeDwarfismGenetic Predisposition to DiseaseHumansMental DisordersMicrotubulesMitosisNeoplasmsSpindle ApparatusAntigenspericentrin

Identifiers

PMID19951897
PMCPMC2812529
OpenAlexW2153602239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.